SIMCERE PHARMAC. GRP LTD (S2P) — Free Cash Flow Generation Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Free Cash Flow Generation Index of 0.57x as of December 2025. Free cash flow of €1.15 Billion represents 1% of operating cash flow (€2.01 Billion). Read SIMCERE PHARMAC. GRP LTD debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for SIMCERE PHARMAC. GRP LTD across 4 annual periods. Explore S2P capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for SIMCERE PHARMAC. GRP LTD (2022–2025)
Year-by-year Free Cash Flow Generation Index for SIMCERE PHARMAC. GRP LTD. For the full company profile including market capitalisation, see S2P stock market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | €1.15 Billion | €2.01 Billion | €862.20 Million | ▲ +26.6% |
| 2024 | 0.45x | €628.54 Million | €1.39 Billion | €762.57 Million | ▲ +108.2% |
| 2023 | -5.49x | €-828.81 Million | €151.05 Million | €979.86 Million | ▼ -1199.0% |
| 2022 | 0.50x | €676.09 Million | €1.35 Billion | €678.00 Million | — |